Arcturus Therapeutics Holdings

$67.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-0.09%) As of 3:16 PM UTC today

Why Robinhood?

You can buy or sell ARCT and other stocks, options, and ETFs commission-free!

About ARCT

Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA. The listed name for ARCT is Arcturus Therapeutics Holdings Inc. Common Stock.

CEO

Joseph E. Payne

Employees

—

Headquarters

San Diego, California

Founded

2013

Market Cap

1.83B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

3.03M

High Today

$69.17

Low Today

$66.51

Open Price

$67.00

Volume

211.63K

52 Week High

$129.71

52 Week Low

$8.51

Collections

Analyst Ratings

58%

of 12 ratings

Buy

58%

Hold

33%

Sell

ARCT Earnings

-$0.92

-$0.61

-$0.31

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, After Hours